RankAlpha logo
Back to Rankings

BIIB

BiogenC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
BIIB vs peer average
56/100
BIIB vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · C 3 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

REGN is the first available peer comparator.

Large-cap biotech peer with a profitable commercial portfolio and pipeline optionality; useful for comparing how BIIB is being valued through product durability plus late-stage pipeline milestones.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerREGNRegeneron
BIIB
Biogen
REGN
Regeneron
Grade
C
C
Momentum
49
70
Value
67
64
Sentiment
53
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs REGN

BIIB / REGN
Grade Position
In line
BIIB vs. peer average (C vs. C)
56/100
Momentum
49
REGN
Value
67
BIIB
Sentiment
53
REGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BIIB
1
REGN
REGN
C
60/100
Even
2
GILD
GILD
B
80/100
-1
3
AMGN
AMGN
D
40/100
+1
4
ZTS
Zoetis Inc Class A Common
C
60/100
Even
5
ALNY
Alnylam Pharmaceuticals Inc Common
C
60/100
Even
REGN is the first peer returned for this comparison set.